Top Markets
#1 Black Phoenix Black Phoenix +356.02%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.09%
#4 Akedo Akedo +48.10%
#5 Acurast Acurast +34.81%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.41%
#7 BasedHype BasedHype +25.95%
#8 Avantis Avantis +23.73%
#9 Cryptopia Cryptopia +21.54%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +16.89%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Classement en actions #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Prix de l'action
$0.0202
Dernière synchronisation: 2024-11-19
Capitalisation boursière
$44.67K
Changement (1 jour)
-0.49%
Changement (1 an)
0.00%
Pays
IL
Échange Notable Labs, Ltd. (NTBL)

Catégorie

Healthcare
Revenus pour Notable Labs, Ltd. (NTBL)
Revenus en Jun 2024 TTM : $3.00K
Selon les derniers rapports financiers de Notable Labs, Ltd., le chiffre d'affaires actuel de l'entreprise (TTM) est de $3.00K. En 2022, l'entreprise a réalisé un chiffre d'affaires de $8.00K une diminution par rapport à le chiffre d'affaires de l'année 2021, qui était de $285.00K. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Notable Labs, Ltd. de 2015 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $3.00K -99.03%
2023 $310.00K 3,775.00%
2022 $8.00K -97.19%
2021 $285.00K -69.09%
2020 $922.00K 64.06%
2019 $562.00K -3.93%
2018 $585.00K -95.78%
2017 $13.86M 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 420,809,900.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 200,709,476.97%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 337,026,123.20%
BE